article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. The company initiated the first legal transfer (as deemed by federal law) to the U.S. territories.

article thumbnail

Expert Gives Delta-8 THC Thumbs Down

Project CBD

Project CBD: Your presentation with Allyn Howlett at the International Cannabinoid Research Society conference in Toronto (June 2023) discussed the chemical conversion of CBD into Δ8-THC (delta-8 THC) and “numerous additional THC isomers. At issue are potent, intoxicating cannabinoids other than cannabis-derived Δ9-THC.

THC 212
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Our lead product, ANEB-001, has the potential to rapidly reverse the effects of acute cannabinoid intoxication, a relatively unknown yet serious affliction that sends more than 5,000 Americans to the hospital emergency department every day.

article thumbnail

United Coalition of Cannabis Associations Successfully Advocated Amendments into AB 45, Establishing A Foundation for Comprehensive Cannabinoid Policy.

Cannabis Law Report

The mission of the United Cannabis Business Association is to establish a comprehensive, statewide cannabinoid policy. Responsible policy prioritizes public health and safety and promotes the viability of both California’s legal cannabis industry and the legal hemp industry. .

article thumbnail

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Veriheal

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). On top of this, 4% considered the cost of CBD to be “high” or “prohibitive,” while 3% were concerned about the legality or potential drug interactions.

article thumbnail

Nextleaf Focused on Owning The Largest Patent Portfolio for the Extraction, Distillation, and Delivery of Cannabinoids

Cannabis Law Report

Nextleaf Solutions’s technologies are focused on transforming cannabis or hemp biomass to a standardized cannabinoid oil as efficiently as possible. It’s capable of extracting cannabinoids from cannabis biomass in a non-flammable and inexpensive co-solvent system using a flow-through ultrasonic extraction system. Flawless Strategy.

article thumbnail

Scientists Think the Synthetic Cannabinoids in Sativex Can Beat Brain Cancer

SpeedWeed

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . “It’s not just street cannabis put into a bottle,” GW Pharmaceutical CEO Justin Gover once told the Guardian. View original article.